Predictors of remission in Cushing’s disease after transsphenoidal endoscopic adenomectomy


如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅或者付费存取

详细

Two-three-day postoperative examination results, such as a serum cortisol level of <388 nmol/l with 94.9% sensitivity and 75.9% specificity and a plasma adrenocorticotropic hormone level of <20 pg/ml with 83.3% sensitivity and 95.8% specificity, can be used as the optimal prognostic criteria for remission in Cushing’s disease one year after transsphenoidal endoscopic adenomectomy.

全文:

受限制的访问

作者简介

N. Kuritsyna

V.A. Almazov National Medical Research Center

Email: leptin-rulit@mail.ru

Yu. Lavrishcheva

V.A. Almazov National Medical Research Center

Email: leptin-rulit@mail.ru

U. Tsoi

V.A. Almazov National Medical Research Center

Email: leptin-rulit@mail.ru

V. Chereblllo

V.A. Almazov National Medical Research Center

Email: leptin-rulit@mail.ru

A. Paltsev

V.A. Almazov National Medical Research Center

Email: leptin-rulit@mail.ru

E. Vasilyeva

V.A. Almazov National Medical Research Center

Email: leptin-rulit@mail.ru

E. Litvinenko

V.A. Almazov National Medical Research Center

Email: leptin-rulit@mail.ru

E. Grineva

V.A. Almazov National Medical Research Center

Email: leptin-rulit@mail.ru

参考

  1. Newell-Price J., Trainer P., Besser G. et al. The diagnosis and differential diagnosis of Cushing’s and pseudo-Cushing’s states // Endocrine Rev. - 2019; 19: 647-72.
  2. Bertagna X., Guignat L., Groussin L. et al. Cushing’s disease // Best Pract. Res. Clin. Endocrinol. Metab. - 2009; 23: 607-23.
  3. Arnaldi G., Angeli A., Atkinson A. et al. Diagnosis and complications of Cushing’s syndrome: a consensus statement // J. Clin. Endocrinol. Metab. - 2003; 88 (12): 5593-602.
  4. Sharma S., Nieman L., Feelders R. Cushing’s syndrome: epidemiology and developments in disease management // Clin. Epidemiol. - 2015; 7: 281-93.
  5. Invitti C., Pecori Giraldi F., De Martin M. et al. The Study Group of the Italian Society of Endocrinology on the Pathophysiology of the Hypotalamic-Pituitary-Adrenal Axis Diagnosis and management of Cushing’s syndrome: results of an Italian multicentre study // J. Clin. Endocrinol. Metab. - 1999; 84: 440-8.
  6. Clayton R., Raskauskiene D., Reulen R. et al. Mortality and morbidity in Cushing’s disease over 50 years in Stoke-on-Trent, UK: audit and meta-analysis of literature // J. Clin. Endocrinol. Metabol. - 2011; 96: 632-42.
  7. Abellan Galiana P., Fajardo Montaflana C., Riesgo Suarez P. et al. Predictors of longterm remission after transsphenoidal surgery in Cushing’s disease // Endocrinol. Nutr. - 2013; 60: 475-82.
  8. Biller B., Grossman A., Stewart P. et al. Treatment of adrenocorticotropindependent Cushing’s syndrome: a consensus statement // J. Clin. Endocrinol. Metab. - 2008; 93: 2454-62.
  9. Hameed N., Yedinak C., Brzana J. et al. Remission rate after transsphenoidal surgery in patients with pathologically confirmed Cushing’s disease, the role of cortisol, ACTH assessment and immediate reoperation: a large single center experience // Pituitary. - 2013; 16: 452-8.
  10. Petersenn S., Beckers A., Ferone D. et al. Outcomes in patients with Cushing’s disease undergoing transsphenoidal surgery: systematic review assessing criteria used to define remission and recurrence // Eur. J. Endocrinol. -2015; 172: 227-39.
  11. Marova E., Kolesnikova G., Arapova S. et al. Factors predicting the outcomes of removal of corticotropinom in Cushing’s disease // Endocrine Surgery. - 2016; 10 (4): 20-30.
  12. Lindsay J., Oldfield E., Stratakis C. et al. The postoperative basal cortisol and CRH tests for prediction of longterm remission from Cushing’s disease after transsphenoidal surgery // J. Clin. Endocrinol. Metab. - 2011; 96: 2057-64.
  13. Ironside N., Chatain G., Asuzu D. et al. Earlier post-operative hypocortisolemia may predict durable remission from Cushing’s disease // Eur. J. Endocrinol. - 2018; 178 (3): 255-63.
  14. Nadezhdina E., Rebrova O., Ivashenko O. et al. Factors affecting the probability of recurrence of the Cushing’s disease within 3 years after effective neurosurgical treatment // Endocrine Surgery. - 2018; 12 (2): 70-80.
  15. Esposito F., Dusick J., Cohan P. et al. Clinical review: Early morning cortisol levels as a predictor of remission after transsphenoidal surgery for Cushing’s disease // J. Clin. Endocrinol. Metab. - 2006; 91: 7-13.
  16. Pereira A., van Aken M., van Dulken H. et al. Long-term predictive value of postsurgical cortisol concentrations for cure and risk of recurrence in Cushing’s disease // J. Clin. Endocrinol. Metab. - 2003; 88: 5858-64.
  17. Tostenaro F., Rodrigues T., Rollin G. et al. Evaluation of Cushing’s disease remission after transsphenoidal surgery based on early serum cortisol dynamics // Clin. Endocrinol. - 2014; 80: 411-8.
  18. Acebes J., Martino J., Masuet C. Early postoperative ACTH and cortisol as predictors of remission in Cushing’s disease // Acta Neurochirurgica. - 2007; 149: 471-7.
  19. El Asmar N., Rajpal A., Selman W. et al. The Value of Perioperative Levels of ACTH, DHEA, and DHEA-S and Tumor Size in Predicting Recurrence of Cushing Disease // J. Clin. Endocrinol. Metab. - 2018; 103 (2): 477-85.
  20. Valassi E., Biller B., Swearingen B. et al. Delayed remission after transsphenoidal surgery in patients with Cushing’s disease // J. Clin. Endocrinol. Metab. - 2010; 95 (2): 601-10.
  21. Alwani R., de Herder W., van Aken M. et al. Biochemical predictors of outcome of pituitary surgery for Cushing’s disease // Neuroendocrinology. - 2010; 91: 169-78.
  22. Colombo P., Dall’Asta C., Barbetta L. et al. Usefulness of the desmopressin test in the postoperative evaluation of patients with Cushing’s disease // Eur. J. Endocrinol. - 2000; 143: 227-34.
  23. Romanholi D., Machado M., Pereira C. et al. Role for postoperative cortisol response to desmopressin in predicting the risk for recurrent Cushing’s disease // Clin. Endocrinol. (Oxf.). - 2008; 69: 117-22.
  24. Le Marc’hadour P., Muller M., Albarel F. et al. Postoperative follow-up of Cushing’s disease using cortisol, desmopressin and coupled dexamethasone-desmopressin tests: a head-to-head comparison // Clin. Endocrinol. - 2015; 83: 216-22.

补充文件

附件文件
动作
1. JATS XML
下载
##common.cookie##